Casa Physicians Alliance News
Improving the Immune Response to Influenza Vaccine in Older Adults
Older adults (65 years of age and older) are subject to immunosenescence, the biological agingprocess that is associated with increased susceptibility to infectious diseases, such as influenza. Immunosenescence also leads to the decreased response to vaccinations, placing adults 65 years of age and older at greater risk of influenza and its complications. 1,2 Influenza virus infection can also exacerbate inflammatory processes, further increasing the risk in these older adults for severe outcomes, such as stroke and acute myocardial infarction. 1,2
Although the Advisory Committee on Immunization Practices, or ACIP, recommends influenza immunization for all eligible adults 65 years of age and older (seniors) and not just those who are frail or unwell, 3 more than one third of seniors in the US were unvaccinated against influenza in the 2015-2016 season, 4 highlighting your key role in seeing that your senior patients are immunized against influenza this year, and every year.
Improving the antibody response to vaccination plays an important role in helping to prevent laboratory-confirmed influenza in the senior population. This branded educational podcast will share the results of key clinical trials utilizing an influenza vaccine specifically designed to help prevent influenza in adults 65 years of age and older.
As we approach the influenza season, Sanofi Pasteur Inc. is here to support you in seeing that your patients 65 years of age and older are immunized against influenza. Please contact me to learn more about influenza’s impact on seniors, your vaccine options, and the tools we have to support your office.
Click the link below to access a brief 5-minute podcast on improving the immune response to influenza vaccine in older adults from Dr. Richard Feldman, Director of the Family Medicine Residency at Franciscan St. Francis Health in Indianapolis, Indiana; Clinical Assistant Professor at the Indiana University School of Medicine; Associate Professor Marian University College of Osteopathic Medicine; and former Indiana State Commissioner of Health.
References: 1. Haq K, McElhaney JE. Immunosenescence: influenza vaccination and the elderly. Curr Opin Immunol. 2014;29:38-42. 2. Castle SC, Uyemura K, Fulop T, Makinodan T. Host resistance and immune responses in advanced age. Clin Geriatr Med. 2007;23(3):463-479. 3. Centers for Disease Control and Prevention. Prevention and control of seasonal influenza with vaccines—recommendations of the Advisory Committee on Immunization Practices, United States, 2016-17 influenza season. MMWR. 2016;65(RR-5):1-52. 4. Centers for Disease Control and Prevention. Flu vaccination coverage, United States, 2015-16 influenza season. http://www.cdc.gov/flu/ fluvaxview/coverage-1516estimates. htm#age-group-adults . Accessed October 12, 2016.
Posted by Shari Smith on 12th January, 2017 | Comments | Trackbacks
Tags: Sanofi, Vaccine Discounts and Rebates, Healthcare Professional, Sanofi Fluzone, Purchasing Program, Physicians Buying Group, Discount Vaccine Program, Sanofi Flu Partners Program, Adult Vaccine, Group Purchasing Organization, Schedule your Flu Shot, Discount Vaccine Buying Program, Influenza Vaccine, Discount Sanofi Vaccines, Vaccine Savings, CASA Physicians Alliance, Vaccine Group, Savings on Adult Vaccines, Vaccine Group Purchasing Program, Seasonal Flu, Influenza, Flu Vaccine
The trackback URL for this page is http://www.casaalliance.net/trackback?post=32962941
There are no trackbacks for this post
There are no comments for this post
Post a Comment
HTML is not allowed in comments, http://... will be automatically linked.